4//SEC Filing
Nunes Anne 4
Accession 0001171843-25-001406
CIK 0000898437other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:18 PM ET
Size
9.4 KB
Accession
0001171843-25-001406
Insider Transaction Report
Form 4
Nunes Anne
SVP, Chief Operations Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-03-10−3,296→ 3,295 totalExercise: $0.00→ Common Stock (3,296 underlying) - Exercise/Conversion
Common Stock
2025-03-10+3,296→ 17,235 total - Tax Payment
Common Stock
2025-03-10$16.62/sh−959$15,939→ 16,276 total
Footnotes (5)
- [F1]Reflects the second vesting installment of RSUs granted on March 9, 2023.
- [F2]Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 460 shares purchased on November 14, 2024.
- [F3]Reflects an aggregate of 959 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2025.
- [F4]Reflects the closing price of ANIK common stock on March 7, 2025, the trading day prior to which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024.
Documents
Issuer
Anika Therapeutics, Inc.
CIK 0000898437
Entity typeother
Related Parties
1- filerCIK 0001982862
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 5:18 PM ET
- Size
- 9.4 KB